跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 98 条关于
“Immedica”
全部
98
临床试验
13
药物
33
机构
36
资讯
16
去年
Immedica Acquires Marinus Pharmaceuticals for $151M, Expanding Rare Disease Portfolio with ZTALMY
去年
Ovid Therapeutics Sells Ganaxolone Royalty Rights to Immedica Pharma for $7 Million
去年
Ravicti Receives Regulatory Approval in Saudi Arabia, Qatar, and Kuwait for Urea Cycle Disorders
5个月前
Taiwan Approves PharmaMar's Zepzelca Combination as First-Line Maintenance Therapy for Advanced Small Cell Lung Cancer
4年前
Aeglea BioTherapeutics Submits BLA for Pegzilarginase as First Potential Treatment for Arginase 1 Deficiency
去年
Cassava Sciences Appoints Joseph Hulihan as Chief Medical Officer to Lead Simufilam Development for TSC-Related Epilepsy
8个月前
Ray Therapeutics Strengthens Leadership Team with Key Executive Appointments to Advance Optogenetic Vision Therapies
去年
DiaMedica Announces ReMEDy2 Trial Updates and Q3 2024 Financial Results
去年
DiaMedica Receives SAHPRA Approval to Commence Phase II Preeclampsia Trial with DM199
6个月前
DiaMedica Receives Health Canada Approval for Phase II Preeclampsia Trial of DM199
第 1 页,共 2 页
上一页
下一页